Filing Date |
T Date |
Ticker |
Sector |
Ind | Industry |
Owner |
oSt |
Rel |
Title |
T |
TVal |
Price |
L |
Qty |
oc |
Own |
H |
r2y |
r1y |
r6m |
r3m |
r6w |
r3w |
r7d |
r3d |
f1d |
f1w |
f1m |
f3m |
f6m |
f1y |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
1/22/24 16:18 | 1/19/24 | IVVD | Health | BioPrd | Biological Products, (No Diag | Adimab, LLC | NH | T | S | -19,750 | 3.95 | 0 | -5,000 | -19 | 21,688 | D | |||||||||||||||
9/1/22 16:28 | 9/1/22 | ADGI | Health | BioPrd | Biological Products, (No Diag | Hering David | MA | DO | CEO | P | 36 | 4.52 | 0 | 8 | New | 8 | D | ||||||||||||||
8/19/22 16:57 | 8/17/22 | ADGI | Health | BioPrd | Biological Products, (No Diag | Elia Marc | MA | DH | See Foot | P.m | 12,195 | 4.28 | 0 | 2,850 | 45 | 9,248 | I | ||||||||||||||
8/12/21 21:27 | 8/10/21 | ADGI | Health | BioPrd | Biological Products, (No Diag | Royan Ajay | MA | DT | P.d | 33,949 | 17.00 | 0 | 1,997 | 22 | 11,242 | I | |||||||||||||||
8/12/21 21:25 | 8/10/21 | ADGI | Health | BioPrd | Biological Products, (No Diag | Mithril II LP | TX | T | P.d | 33,949 | 17.00 | 0 | 1,997 | 22 | 11,242 | D | |||||||||||||||
8/12/21 21:24 | 8/10/21 | ADGI | Health | BioPrd | Biological Products, (No Diag | McGuire Terrance | MA | D | P.d | 8,500 | 17.00 | 0 | 500 | 498 | I | ||||||||||||||||
8/12/21 21:01 | 8/10/21 | ADGI | Health | BioPrd | Biological Products, (No Diag | Redmile Group, LLC | CA | T | P.d | 24,990 | 17.00 | 0 | 1,470 | 77 | 3,391 | I |
| D | Derivative transaction in filing (usually option exercise) |
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
| A | Amended filing |
| E | Error detected in filing |
| S - Sale | Sale of securities on an exchange or to another person |
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
| P - Purchase | Purchase of securities on an exchange or from another person |